PANDAA qDx™ SARS-CoV-2

Real-time PCR detection of COVID-19 Disease

Kits available for on-site COVID-19 testing by CLIA and high-complexity labs

Contact: COVID19@aldatubio.com

PANDAA qDx SARS-CoV-2

Aldatu Enables On-site COVID-19 Testing at Major Boston Hospital

March 19th, 2020
Despite national supply constraints, one of the major Boston hospitals now has the ability to do rapid in-house testing and they are conducting the highest volume of on-site hospital testing in New England, thanks to Boston-based startup, Aldatu Biosciences.Read More >>

Aldatu Enables On-site COVID-19 Testing at Major Boston Hospital

Aldatu Enables On-site COVID-19 Testing at Major Boston Hospital

March 19th, 2020

Despite national supply constraints, one of the major Boston hospitals now has the ability to do rapid in-house testing and they are conducting the highest volume of on-site hospital testing in New England, thanks to Boston-based startup, Aldatu Biosciences.Read More >>

Aldatu Biosciences Expands PANDAA Platform Beyond HIV with SBIR for the First Pan-Lineage Lassa Fever Test
April 29th, 2019
Aldatu Biosciences Awarded $3 Million NIH SBIR Contract for Early HIV Drug Resistance Detection
October 15th, 2018
Aldatu Biosciences announces addition of Michael Henry and Marta Fernández Suárez to the Scientific and Business Advisory Board
August 3rd, 2017
In Memory of Mark Wainberg: Aldatu Advisor and HIV Pioneer
April 13th, 2017